Document is current
Any future updates will be listed below
-
Authors
Bielefeld, C.
Hugo, T.
Sievers, N.
Ketteler, P.
Biewald, E.
Kiefer, T.
Papaioannou, K.
Tüller, P.
Ryl, T.
Busch, M.
Rawitzer, J.
Schildhaus, H.-U.
Ting, S.
-
Funding
Funding for this research was provided by:
Deutsche Kinderkrebsstiftung (DKS2020.14)
Deutsche Kinderkrebsstiftung (DKS2024.08)
- License Information
-
More Information
Article History
Received: 27 May 2025
Revised: 28 July 2025
Accepted: 1 August 2025
First Online: 21 August 2025
Declarations
Ethical approval: This study has been approved by local ethics committees: 13–5405-BO [12/04/2023], Ethik-Kommission der Medizinischen Fakultät der Universität Duisburg-Essen, and 2024–3926-evBO [FF61/2014], Ethik-Kommission bei der Landesärztekammer Hessen.
Conflict of interest: HUS is an employee of Discovery Life Sciences; honoraria for advisory board memberships, research support, and reimbursements from Daiichi Sankyo, AstraZeneca, BMS, Astellas, Zytomed Systems, ZytoVision, MSD, Merck, Agilent, and Roche have been paid to the employer. All remaining authors declare no conflict of interest.
